Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity

v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
Public warrants exercises
Private warrants exchange
Conversion of shares of class B common stock to class A common stock
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
Public warrants exercises
Common Stock
Class A Common Stock
Private warrants exchange
Common Stock
Class A Common Stock
Conversion of shares of class B common stock to class A common stock
Common Stock
Class B Common Stock
Common Stock
Class B Common Stock
Conversion of shares of class B common stock to class A common stock
Treasury Stock
Additional Paid-In Capital
Additional Paid-In Capital
Public warrants exercises
Additional Paid-In Capital
Private warrants exchange
Additional Paid-In Capital
Conversion of shares of class B common stock to class A common stock
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Noncontrolling Interests
Noncontrolling Interests
Conversion of shares of class B common stock to class A common stock
Beginning balance (in shares) at Oct. 19, 2021         9,976,164                                
Ending balance (in shares) at Oct. 20, 2021         18,750,000 18,750,000                              
Beginning balance (in shares) at Dec. 31, 2022             200,298,834       8,040,540                    
Beginning balance at Dec. 31, 2022 $ 1,467.2           $ 0.0       $ 0.0   $ 0.0 $ 1,882.4       $ (408.5) $ (75.7) $ 69.0  
Beginning balance (in shares) at Dec. 31, 2022                         0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Warrant redemptions / Conversion of shares (in shares)             100     193,207   (193,207)                  
Conversion of shares and warrants exercises/exchange       $ 0.0                         $ 1.6       $ (1.6)
Stock issued for vested restricted stock units (in shares)             40,764                            
Stock compensation to directors in lieu of cash compensation (in shares)             12,090                            
Stock compensation to directors in lieu of cash compensation 0.1                         0.1              
Issuance of shares of class A common stock, net of offering costs (in shares)             17,142,857                            
Issuance of shares of class A common stock, net of offering costs 149.8                         149.8              
Stock-based compensation expense 5.5                         5.5              
Net loss (42.9)                                 (41.9)   (1.0)  
Other comprehensive income (loss) 8.3                                   8.0 0.3  
Ending balance (in shares) at Mar. 31, 2023             217,687,852       7,847,333                    
Ending balance at Mar. 31, 2023 1,588.0           $ 0.0       $ 0.0   $ 0.0 2,039.4       (450.4) (67.7) 66.7  
Ending balance (in shares) at Mar. 31, 2023                         0                
Beginning balance (in shares) at Dec. 31, 2022             200,298,834       8,040,540                    
Beginning balance at Dec. 31, 2022 1,467.2           $ 0.0       $ 0.0   $ 0.0 1,882.4       (408.5) (75.7) 69.0  
Beginning balance (in shares) at Dec. 31, 2022                         0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Net loss (71.3)                                        
Other comprehensive income (loss) 7.8                                        
Ending balance (in shares) at Jun. 30, 2023             217,933,337       7,847,333                    
Ending balance at Jun. 30, 2023 1,564.5           $ 0.0       $ 0.0   $ (0.7) 2,045.6       (478.1) (68.3) 66.0  
Ending balance (in shares) at Jun. 30, 2023                         87,647                
Beginning balance (in shares) at Mar. 31, 2023             217,687,852       7,847,333                    
Beginning balance at Mar. 31, 2023 1,588.0           $ 0.0       $ 0.0   $ 0.0 2,039.4       (450.4) (67.7) 66.7  
Beginning balance (in shares) at Mar. 31, 2023                         0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Stock issued for vested restricted stock units (in shares)             323,350                            
Stock repurchased to satisfy tax withholding for vesting restricted stock units (in shares)             87,647           87,647                
Stock repurchased to satisfy tax withholding for vesting restricted stock units (0.7)                       $ (0.7)                
Stock compensation to directors in lieu of cash compensation (in shares)             9,782                            
Stock compensation to directors in lieu of cash compensation 0.1                         0.1              
Stock-based compensation expense 6.1                         6.1              
Net loss (28.4)                                 (27.7)   (0.7)  
Other comprehensive income (loss) (0.6)                                   (0.6) 0.0  
Ending balance (in shares) at Jun. 30, 2023             217,933,337       7,847,333                    
Ending balance at Jun. 30, 2023 1,564.5           $ 0.0       $ 0.0   $ (0.7) 2,045.6       (478.1) (68.3) 66.0  
Ending balance (in shares) at Jun. 30, 2023                         87,647                
Beginning balance (in shares) at Dec. 31, 2023         218,177,832 7,787,333 218,177,832       7,787,333                    
Beginning balance at Dec. 31, 2023 $ 1,550.0           $ 0.0       $ 0.0   $ (1.3) 2,056.5       (505.4) (65.3) 65.5  
Beginning balance (in shares) at Dec. 31, 2023 149,076                       149,076                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Warrant redemptions / Conversion of shares (in shares)                   460,910   (460,910)                  
Conversion of shares and warrants exercises/exchange       0.0                         3.8       (3.8)
Stock issued for vested restricted stock units (in shares)             88,171                            
Stock compensation to directors in lieu of cash compensation (in shares)             8,420                            
Stock compensation to directors in lieu of cash compensation $ 0.1                         0.1              
Stock-based compensation expense 3.5                         3.5              
Net loss (26.5)                                 (25.8)   (0.7)  
Other comprehensive income (loss) (9.2)                                   (8.9) (0.3)  
Ending balance (in shares) at Mar. 31, 2024             218,735,333       7,326,423                    
Ending balance at Mar. 31, 2024 1,517.9           $ 0.0       $ 0.0   $ (1.3) 2,063.9       (531.2) (74.2) 60.7  
Ending balance (in shares) at Mar. 31, 2024                         149,076                
Beginning balance (in shares) at Dec. 31, 2023         218,177,832 7,787,333 218,177,832       7,787,333                    
Beginning balance at Dec. 31, 2023 $ 1,550.0           $ 0.0       $ 0.0   $ (1.3) 2,056.5       (505.4) (65.3) 65.5  
Beginning balance (in shares) at Dec. 31, 2023 149,076                       149,076                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Net loss $ (38.5)                                        
Other comprehensive income (loss) $ (14.7)                                        
Ending balance (in shares) at Jun. 30, 2024 18,750,000       225,359,792 6,858,290 225,359,792       6,858,290                    
Ending balance at Jun. 30, 2024 $ 1,564.1           $ 0.0       $ 0.0   $ (2.2) 2,132.4       (542.9) (79.5) 56.3  
Ending balance (in shares) at Jun. 30, 2024 232,842                       232,842                
Beginning balance (in shares) at Mar. 31, 2024             218,735,333       7,326,423                    
Beginning balance at Mar. 31, 2024 $ 1,517.9           $ 0.0       $ 0.0   $ (1.3) 2,063.9       (531.2) (74.2) 60.7  
Beginning balance (in shares) at Mar. 31, 2024                         149,076                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Warrant redemptions / Conversion of shares (in shares)               3,978,418 1,768,000 468,133   (468,133)                  
Conversion of shares and warrants exercises/exchange   $ 42.3 $ 18.3 $ 0.0                     $ 42.3 $ 18.3 $ 3.9       $ (3.9)
Stock issued for vested restricted stock units (in shares)             485,972                            
Stock repurchased to satisfy tax withholding for vesting restricted stock units (in shares)             83,766           83,766                
Stock repurchased to satisfy tax withholding for vesting restricted stock units (0.9)                       $ (0.9)                
Stock compensation to directors in lieu of cash compensation (in shares)             7,702                            
Stock compensation to directors in lieu of cash compensation 0.1                         0.1              
Stock-based compensation expense 3.9                         3.9              
Net loss (12.0)                                 (11.7)   (0.3)  
Other comprehensive income (loss) $ (5.5)                                   (5.3) (0.2)  
Ending balance (in shares) at Jun. 30, 2024 18,750,000       225,359,792 6,858,290 225,359,792       6,858,290                    
Ending balance at Jun. 30, 2024 $ 1,564.1           $ 0.0       $ 0.0   $ (2.2) $ 2,132.4       $ (542.9) $ (79.5) $ 56.3  
Ending balance (in shares) at Jun. 30, 2024 232,842                       232,842